An overview of lichen sclerosus

Clinical Obstetrics and Gynecology

Volumn 48, Issue 4, 2005, Pages 808-817

  Val, Isabel ^a,b   Almeida, Gutemberg ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ANDROSTANOLONE; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCIPOTRIOL; CHLOROQUINE; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; ETRETIN; ETRETINATE; HYDROXYCHLOROQUINE; OXATOMIDE; PIMECROLIMUS; PROGESTERONE; RETINOIC ACID; RETINOID; SEX HORMONE; STANOZOLOL; STEROID; TACROLIMUS; TESTOSTERONE; TESTOSTERONE PROPIONATE;

ACNE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HEREDITY; HIRSUTISM; HISTOLOGY; HUMAN; IMMUNOLOGY; INCIDENCE; INFECTION; INJURY; LIBIDO DISORDER; LICHEN SCLEROSUS ET ATROPHICUS; MENSTRUAL IRREGULARITY; PATHOGENESIS; REVIEW; VIRILIZATION;

FEMALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; VULVAR LICHEN SCLEROSUS;

EID: 29644434210     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000179635.64663.3d     Document Type: Review

References (61)

1. Hallopeau H. Du lichen plan et particulièrement de sa forme atrophique: lichen plan scléreux. Ann Dermatol Syphiligr (Paris). 1887;8:790-791.
2. Darier J. Lichen plan scléreux. Ann Dermatol Syphiligr (Paris). 1892;23:833-837.
3. Friedrich EG. Lichen sclerosus. J Reprod Med. 1976;17:147-154.
4. Wallace HJ. Lichen sclerosus et atrophicus. Trans St John's Dermatol Soc (England). 1971;57:9-30.
5. Sahn EE, Bluestein EL, Oliva S. Familial lichen sclerosus et atrophicus in childhood. Pediatr Dermatol. 1994;11:160-163.
6. Ridley CM. Genital lichen sclerosus (lichen sclerosus et atrophicus) in childhood and adolescence. JR Soc Med. 1993;86:69-75.
7. Meyrick TRH, Ridley CM, McGibbon DH, et al. Anogenital lichen sclerosus in women. JR Soc Med. 1996;89:694-698.
8. Goolamali SK, Barnes EW, Irvine WJ, et al. Organ specific antibodies in patients with lichen sclerosus. BMJ. 1974;4:78-79.
9. Harrigton CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus. Br J Dermatol. 1981;104:563-566.
10. Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity - a study of 350 women. Br J Dermatol. 1988;118:41-46.
11. Powell J, Wojnarowska F, Winsey S. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol. 2000; 142:481-484.
12. Barker LP, Gross P. Lichen sclerosus et atrophicus of the female genitalia: a clinical study and diagnostic guide. Arch Dermatol. 1962;85:362-373.
13. Murphy FR, Lipa M, Haberman HF. Familial vulvar dystrophy of lichen sclerosus type. Arch Dermatol. 1982;118:329-331.
14. Pelisse M, Fischesser D, Moyal M. Lichen scléreux vulvaire (LSV) infantile. Ann Dermatol Venereol. 1984;111:741-742.
15. Meyrich Thomas RH, Kennedy CT. The development of lichen sclerosus et atrophicus in monozygotic twin girls. Br J Dermatol. 1986;114:377-379.
16. Purcell KG, Spencer LV, Simpson PM. HLA antigens in lichen sclerosus et atrophicus. Arch Dermatol. 1990;126:1043-1045.
17. Marren P, Yell J, Charnock FM. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol. 1995;132:197-203.
18. Clay FE, Cork MJ, Tarlow JK. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet. 1994;94:407-410.
19. Friedrich EG Jr, Kalra PS. Serum levels of Sex hormones in vulval lichen sclerosus and the effect of topical testosterone. N Engl J Med. 1984;310:488-491.
20. Shirer JA Jr, Ray MC. Familial occurrence of lichen sclerosus et atrophicus. Arch Dermatol. 1987;123:485-488.
21. Feldmann R, Harms M. Lichen sclerosus et atrophicus. Hautarzt. 1991;42:147-153.
22. Kohlberger P, Joura EA, Bancher D, et al. Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study. J Soc Gynecol Investig. 1998;5:331-333.
23. Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med. 1995;40:351-354.
24. Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol. 2002;147:640-649.
25. Weide B, Walz T, Garbe C. Is morphea caused by Borrelia burgdorferi? A review. Br J Dermatol. 2000;142:636-644.
26. Karram M, Tabor B, Smotkin D, et al. Detection of human papillomavirus deoxyribonucleic acid from vulvar dystrophies and vulvar intraepithelial neoplastic lesions. Am J Obstet Gynecol. 1988;159:22-23.
27. Neill SM, Leibowitch M, Pelisse M. Lichen sclerosus, invasive squamous cell carcinoma, and human papillomavirus. Am J Obstet Gynecol. 1990;162:1633-1634.
28. Kiene P, Mild-Langosh K, Löning T. Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus. Arch Dermatol Res. 1991;283:445-448.
29. Milligan A, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus following sunburn. Clin Exp Dermatol. 1988;13:36-37.
30. Yates VM, King CM, Dave VK. Lichen sclerosus et atrophicus following radiation therapy. Arch Dermatol. 1985;121:1044-1047.
31. Pass CJ. An unusual variant of lichen sclerosus et atrophicus: delayed appearance in a surgical scar. Cutis. 1984;33:405-408.
32. Whimster IW. The natural history of endogenous skin malignancy as a basis for experimental research. Trans Rep St John's Dermatol Soc (England). 1973;59:195-224.
33. Farrell AM, Dean D, Charnock FM. Alterations in distribution of tenascin, fibronectin and fibrinogen in vulval lichen sclerosus. Dermatology. 2000;201:223-229.
34. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 1998;10:602-608.
35. Mihara Y, Mihara M, Hagari Y. Lichen sclerosus et atrophicus. A histological, immunohistochemical and electron microscopy study. Arch Dermatol Res. 1994;286:434-442.
36. Godeau G, Frances C, Hornebeck W, et al. Isolation and partial characterisation of an elastase-type protease in human vulval fibroblasts: its possible involvement in vulvar elastic tissue destruction of patients with lichen sclerosus et atrophicus. J Invest Dermatol. 1982;78:270-279.
37. Carli P, Cattaneo A, Pimpinelli N, et al. Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica. 1991;182:18-22.
38. Bracco GL, Carli P, Sonni L. A clinical and histological effect of topical treatments of vulval lichen sclerosus. J Reprod Med. 1993; 38:37-40.
39. Carlson JÁ, Grabowski R, Chichester P, et al. Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous: implications for pathogenesis. Am J Dermatopathol. 2000;22:7-16.
40. Vanin K, Scurry J, Thorne H, et al. Overexpression of wild-type 53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. J Invest Dermatol. 2002;119:1027-1033.
41. Rolfe KJ, MacLean AB, Crow JC. TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer. 2003;89:2249-2253.
42. Ridley CM, Frankman O, Jones IS, et al. New nomenclature for vulvar disease. International Society for the Study of Vulvar Disease. Hum Pathol. 1989;20:495-496.
43. Hewitt J. Histologic criteria for lichen sclerosus of the vulva. J Reprod Med. 1986;31:781-787.
44. Leibowitch M, Neill S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990;97:1135-1139.
45. Haefner HK, Tate JE, McLachlin CM, et al. Vulvar intraepithelial neoplasia. Age, morphological, phenotype, papillomavirus DNA and coexisting invasive carcinoma. Hum Pathol. 1995;26:147-154.
46. Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther. 2004;17:28-37.
47. Dalziel KL, Millard PRP, Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol. 1991;124:461-464.
48. Tosti A, Guerra L, Manuzz P, et al. Contact dermatitis from clobetasol propionate. Contact Dermatitis. 1987;17:256-257.
49. Cinberg BL. Postmenopausal pruritus vulvae. Am J Obstet Gynecol. 1945;49:647-657.
50. Friedrich EG. Topical testosterone for benign vulvar dystrophy. Obstet Gynecol. 1971;37:677-686.
51. Sideri M, Origoni M, Spinaci L, et al. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet. 1994;46:53-56.
52. Jasionowski EA, Jasionowski PA. Topical progesterone in treatment of vulvar dystrophy. Preliminary report of five cases. Am J Obstet Gynecol. 1977;127:667-670.
53. Niinimäki A, Kallioinen M, Oikarinen A. Etretinate reduces connective tissue degeneration in lichen sclerosus et atrophicus. Acta Derm Venereol (Stockh). 1989;69:439-442.
54. Bousema MT, Rompannen U, Geiger JM, et al. Acitretin in the treatment of lichen sclerosus of the vulva: a double blind placebo controlled study. J Am Acad Dermatol. 1994;30:225-231.
55. Virgili A, Corazza M, Bianchi A, et al. Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy. J Reprod Med. 1995;40:614-618.
56. Assmann T, Becker-Wegerich P, Grewe M, et al. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol. 2003;48:935-937.
57. Smith YR, Haefner H. Vulvar lichen sclerosus. Pathophysiology and treatment. Am J Clin Dermatol. 2004;5:105-125.
58. Rouzier R, Haddad B, Deyrolle C, et al. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. Am J Obstet Gynecol. 2002;186:49-52.
59. Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol. 1997;136:356-359.
60. August PJ, Milward TM. Cryosurgery in the treatment of lichen sclerosus et atrophicus of the vulva. Br J Dermatol. 1980;103:667-670.
61. Fisher G, Rogers M. Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol. 1997;14:235-238.